A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma

Cutaneous melanoma is the most malignant skin cancer. Biomarkers for stratifying patients at initial diagnosis and informing clinical decisions are highly sought after. Here we classified melanoma patients into three immune subtypes by single-sample gene-set enrichment analysis. We further identifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Ying, Chen, Mei-Ju May, Liang, Han, Ma, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985195/
https://www.ncbi.nlm.nih.gov/pubmed/33753855
http://dx.doi.org/10.1038/s42003-021-01911-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985195/
https://www.ncbi.nlm.nih.gov/pubmed/33753855
http://dx.doi.org/10.1038/s42003-021-01911-x

Ejemplares similares